|
Welcome to the Drug Discovery Online newsletter, delivering weekly updates on the latest developments in drug discovery and early-stage development. Based on your professional interests, we believe you’ll find it useful for staying informed on emerging technologies and scientific advances, identifying new approaches to discovery and preclinical research, and connecting with potential partners and solution providers.
If not, you can unsubscribe at any time.
| SPONSOR |
|
|
|
| The World Patient Safety Congress Americas (formerly known as World Drug Safety Congress Americas) returns to the Thomas M.Menino Convention & Exhibition Center, Boston from October 13-15, 2026. This premier event brings together over 1,800 leaders from pharma, biotech, and regulatory bodies to explore the future of pharmacovigilance. With a focus on AI, automation, and patient-centricity, the congress provides a vital platform for industry experts to share innovative strategies and ensure safety excellence across pharmaceutical drugs and medical devices. |
|
|
|
|
By Ray Dogum, Chief Editor, Drug Discovery Online | Rh disease has been preventable for decades. Yet babies still die worldwide because access, supply, and infrastructure have not caught up. | |
|
|
|
|
|
|
|
| Residual DNA Testing Across Biotherapeutics | Webinar | QIAGEN | Residual host cell DNA testing can create bottlenecks. Learn how digital PCR supports more consistent quantification, simpler method deployment, and faster in-process and lot release decisions. |
|
|
| Automated Library Prep For A Nanopore DNA Barcoding Protocol | Application Note | INTEGRA Biosciences | A streamlined workflow reduces reagent use and hands‑on time while preserving long‑read sequencing quality. See how multiplexed offer an efficient option for scaling or mobilizing sequencing efforts. |
|
|
| Fluorochrome And Laser Reference Guide | Poster | BD Biosciences | Match fluorochromes with lasers for precise flow cytometry. Uncover brightness levels, antigen pairing recommendations, and tips to reduce nonspecific binding for optimal panel design and reliable results. |
|
|
|
|
|
|